Healthcare provider profile · identity verified

Maryam Hamid, MD

Internal Medicine · CONCORD, NC · NPI 1043717176

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	571	178
Amlodipine Besylate	Amlodipine Besylate	451	134
Omeprazole	Omeprazole	384	120
Levothyroxine Sodium	Levothyroxine Sodium	377	101
Lisinopril	Lisinopril	329	94
Metoprolol Succinate	Metoprolol Succinate	271	88
Tramadol Hcl	Tramadol Hcl	210	53
Losartan Potassium	Losartan Potassium	207	57
Alprazolam	Alprazolam	189	43
Potassium Chloride	Potassium Chloride	184	54
Trazodone Hcl	Trazodone Hcl	184	53
Furosemide	Furosemide	181	61
Prednisone	Prednisone	179	119
Gabapentin	Gabapentin	153	55
Rosuvastatin Calcium	Rosuvastatin Calcium	153	48
Meloxicam	Meloxicam	152	41
Metformin Hcl Er	Metformin Hcl	151	49
Pravastatin Sodium	Pravastatin Sodium	149	38
Sertraline Hcl	Sertraline Hcl	147	42
Simvastatin	Simvastatin	144	34
Duloxetine Hcl	Duloxetine Hcl	133	41
Valsartan	Valsartan	132	41
Zolpidem Tartrate	Zolpidem Tartrate	121	26
Metoprolol Tartrate	Metoprolol Tartrate	120	37
Eliquis	Apixaban	117	33
Alendronate Sodium	Alendronate Sodium	114	29
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	112	33
Celecoxib	Celecoxib	108	31
Metformin Hcl	Metformin Hcl	107	35
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	106	37
Montelukast Sodium	Montelukast Sodium	105	31
Glipizide Er	Glipizide	100	30
Azithromycin	Azithromycin	99	85
Hydrochlorothiazide	Hydrochlorothiazide	99	29
Escitalopram Oxalate	Escitalopram Oxalate	95	29
Tamsulosin Hcl	Tamsulosin Hcl	93	26
Albuterol Sulfate Hfa	Albuterol Sulfate	92	34
Bupropion Xl	Bupropion Hcl	92	24
Jardiance	Empagliflozin	90	17
Lorazepam	Lorazepam	90	21
Pantoprazole Sodium	Pantoprazole Sodium	88	28
Fluoxetine Hcl	Fluoxetine Hcl	82	29
Glipizide	Glipizide	82	18
Ozempic	Semaglutide	80	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	79	21
Clonazepam	Clonazepam	78	16
Fluticasone Propionate	Fluticasone Propionate	78	41
Baclofen	Baclofen	74	22
Buspirone Hcl	Buspirone Hcl	61	17
Mounjaro	Tirzepatide	59	12
Irbesartan	Irbesartan	57	12
Clopidogrel	Clopidogrel Bisulfate	54	20
Atenolol	Atenolol	52	15
Tizanidine Hcl	Tizanidine Hcl	52	14
Allopurinol	Allopurinol	51	17
Mirtazapine	Mirtazapine	51	15
Carvedilol	Carvedilol	50	15
Esomeprazole Magnesium	Esomeprazole Magnesium	49	16
Warfarin Sodium	Warfarin Sodium	49	16
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	47	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	45	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	42	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Synthroid	Levothyroxine Sodium	41	suppressed
Benazepril Hcl	Benazepril Hcl	40	suppressed
Temazepam	Temazepam	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	12
Farxiga	Dapagliflozin Propanediol	36	suppressed
Hydralazine Hcl	Hydralazine Hcl	35	suppressed
Torsemide	Torsemide	35	12
Januvia	Sitagliptin Phosphate	34	suppressed
Lovastatin	Lovastatin	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Spironolactone	Spironolactone	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	11
Fenofibrate	Fenofibrate	33	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	33	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	32	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Promethazine Hcl	Promethazine Hcl	32	suppressed
Estradiol	Estradiol	31	12
Ibuprofen	Ibuprofen	31	suppressed
Cephalexin	Cephalexin	30	28
Valacyclovir	Valacyclovir Hcl	29	12
Azelastine Hcl	Azelastine Hcl	28	suppressed
Ezetimibe	Ezetimibe	28	11
Insulin Lispro Kwikpen U-100	Insulin Lispro	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Famotidine	Famotidine	27	13
Myrbetriq	Mirabegron	27	suppressed
Naproxen	Naproxen	27	12
Tresiba Flextouch U-100	Insulin Degludec	27	suppressed
Meclizine Hcl	Meclizine Hcl	26	12
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	25	suppressed
Fluconazole	Fluconazole	25	19
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	25	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	15
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Diazepam	Diazepam	20	suppressed
Fenofibrate	Fenofibrate,micronized	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Loperamide	Loperamide Hcl	19	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Colchicine	Colchicine	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Finasteride	Finasteride	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Primidone	Primidone	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Levofloxacin	Levofloxacin	14	11
Methylprednisolone	Methylprednisolone	14	14
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	14	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Linzess	Linaclotide	12	suppressed
Livalo	Pitavastatin Calcium	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Tiadylt Er	Diltiazem Hcl	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error